The kallikrein-kinin system: its significance in circulatory failure and the effect of angiotensin I-converting enzyme inhibitors
Ol'binskaia, L.I.; Golokolenova, G.M.; Kuznetsov, V.A.
Terapevticheskii Arkhiv 66(9): 88-92
1994
ISSN/ISBN: 0040-3660 PMID: 7992226 Document Number: 423570
Document emailed within 1 workday
Related Documents
Kondo, K.; Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Morotomi, Y.; Tanaka, K. 1985: Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system Nihon Jinzo Gakkai Shi 27(3): 337-342Matthews, P.G.; Johnston, C.I. 1979: Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225) Advances in Experimental Medicine and Biology 120b: 447-457
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Bönner, G. 1988: Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors? Zeitschrift für Kardiologie 77(Suppl 3): 23-27
Mikunis, R.I.; Salobaĭ, V.A. 1986: Dynamics of the kallikrein-kinin system in patients with recurrent rheumatic carditis associated with heart defects after administration of inhibitors of the kallikrein-kinin system in complex antirheumatic therapy Terapevticheskii Arkhiv 58(7): 89-91
Rosen, B.; Weiss, M.; Zimlichman, R. 1992: Mechanism of action of the angiotensin converting enzyme inhibitors: role of kallikrein kinins and prostaglandins Harefuah 122(5): 305-308
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Textor, S.C. 1997: Renal failure related to angiotensin-converting enzyme inhibitors Seminars in Nephrology 17(1): 67-76
McMurray, J.J. 1998: Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? European Heart Journal 19(Suppl): L15-L21
Svarstad, E.; Willassen, Y.; Iversen, B.M. 1992: Severe renal failure during treatment with angiotensin-converting enzyme inhibitors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(4): 463-465
Jasik, M.; Zdrojewicz, Z.; Stawicki, S. 1999: The activity of renin-angiotensin-aldosterone system (RAA) and possibilities of application angiotensin converting enzyme inhibitors (ACE I) in selected diseases of endocrine glands Wiadomosci Lekarskie 52(3-4): 202-210
Hosoki, K.; Takeyama, K.; Minato, H.; Fukuya, F.; Kawahara, S.; Kadokawa, T. 1986: Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals Arzneimittel-Forschung 36(1): 77-83
Inzhutova, A.I.; Salmina, A.B.; Petrova, M.M. 2007: Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes Kardiologiia 47(8): 49-52
Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906
González-Juanatey, J.R. 2000: Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose Medicina Clinica 114 Suppl. 2: 24-27
Thilly, N.; Zannad, Fïez.; Dufay, E.; Juillière, Y.; Briançon, S. 2003: Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines Therapie 58(4): 341-349
Ghali, J.K.; Giles, T.; Gonzales, M.; Horswell, R.; Kumar, S.; Lejuene, A.; Livaudais, G.F.; Sarkar, I.C. 1997: Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 149(12): 474-484
Olinic, N.; Vida-Simiti, L.; Cristea, A.; Mureşan, A.; Pop, S.; Teşanu, E. 1994: Correlation between fibronectin and cardiothoracic ratio in heart failure treated with angiotensin converting enzyme inhibitors Romanian Journal of Internal Medicine 32(4): 253-257
Paul, M.; Hermann, K.; Printz, M.; Lang, R.E.; Unger, T.; Ganten, D. 1983: The brain angiotensin system: subcellular localization and interferences with converting enzyme inhibitors Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 1(1): 9-15